Your browser doesn't support javascript.
loading
Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer.
Sundar, R; Huang, K K; Qamra, A; Kim, K-M; Kim, S T; Kang, W K; Tan, A L K; Lee, J; Tan, P.
  • Sundar R; Department of Haematology-Oncology, National University Health System, Singapore; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Huang KK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Qamra A; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Kim KM; Department of Pathology and Translational Genomics.
  • Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Tan ALK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.
  • Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: jyunlee@skku.edu.
  • Tan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore; Biomedical Research Council, Agency for Science, Technology and Research, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore; SingHealth/Duke-NUS Institute of Precision Medicine, Nati
Ann Oncol ; 30(3): 424-430, 2019 03 01.
Article en En | MEDLINE | ID: mdl-30624548
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Regiones Promotoras Genéticas / Epigenómica / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Regiones Promotoras Genéticas / Epigenómica / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article